RESERPINE AND HYDROFLUMETHIAZIDE (HYDROFLUMETHIAZIDE; RESERPINE) — FDA Approval ANDA088907 (PAR PHARM)
RESERPINE AND HYDROFLUMETHIAZIDE (HYDROFLUMETHIAZIDE; RESERPINE) — FDA Approval ANDA088907 (PAR PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RESERPINE AND HYDROFLUMETHIAZIDE; Active ingredients: HYDROFLUMETHIAZIDE; RESERPINE; Application number: ANDA088907.
| Brand name | RESERPINE AND HYDROFLUMETHIAZIDE |
|---|---|
| Active ingredients | HYDROFLUMETHIAZIDE; RESERPINE |
| Application number | ANDA088907 |
| Sponsor | PAR PHARM |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19850920 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →